Introduction:
=============

Acute kidney injury (AKI) is a frequent and potentially life-threatening syndrome, with high costs for patients and the healthcare systems ([@B1]). Overall, 5.5% of all emergency department patients had acute kidney injury in one study ([@B2]). AKI is defined as a rise in creatinine, 50% from its baseline value, and/or a fall in the glomerular filtration rate (GFR) by 25%, and/or a decrease in urine output reaching less than 0.5 ml/kg/h for 6 h or more ([@B3]).  AKI in patients is associated with higher mortality. Patients with severe sepsis and septic shock exhibit a complex metabolic acidosis upon intensive care unit admission, caused predominantly by hyperchloremic acidosis, which is more pronounced in non-survivors ([@B4]). Normally, the major renal defense against metabolic acidosis is the net urinary excretion of strong anions, such as chloride, and the retention of strong cations ([@B5]). This mechanism becomes impaired in AKI patients. An early diagnosis is crucial for prompt management of AKI to anticipate acute renal dysfunction. The purpose of this study was to investigate the usefulness of hypercloremic metabolic acidosis (HCMA) levels evaluated, using an arterial blood gas (ABG) analysis derived formula, for early suspicion of AKI in emergency department (ED).

Methods:
========

**Study design and setting**

In the present retrospective observational study, eligible patients who were admitted to University Hospital of Marcianise, Italy, from January 2017 to March 2017, were evaluated regarding HCMA level and its' correlation with renal function. Ethical Committee of North Campania approved the protocol of the present study and all researchers adhered to the principles of the Helsinki declaration during the study period. Additionally, a consent form was obtained from patients.

**Participants**

Adult (\>18 years old) critically ill patients (Acute Physiology and Chronic Health Evaluation (APACHE II) index \>18) in emergency department were subdivided in the non-AKI (with normal creatinine levels and GFR \> 90 ml/min/1.73 m2) and the AKI group according to KDIGO guideline. AKI patients were defined as patients whose serum creatinine had increased to ≥ 0.3 mg/dl (26.5 micrmol/L) within 48 hours or 1.5-fold from the baseline, which was known or presumed to have occurred in the preceding 7 days, with decrease in urine output, according KDIGO guidelines ([@B3],[@B8]).

Adults with chronic kidney disease or need for renal replacement therapy, those not giving consent, less than 18 years of age, history of acute gastrointestinal and post-operative patients were excluded. The Acute Physiology and Chronic Health Evaluation (APACHE II) score and Charlson Comorbidity Index (CCI) ([@B6], [@B7]) were calculated from the patient charts.

**Data gathering and measurements**

Demographic and clinical characteristics, patient diagnoses, procedures (e.g. laboratory tests), treatments/interventions and patient outcomes were extracted from patients' profiles by an emergency medicine specialist who was responsible for data gathering and patients were enrolled using random sampling method.

Glomerular filtration rate (GFR) was evaluated via CKD-EPIdemiology Collaboration (CKD-EPI) equation ([@B8]). Serum levels of albumin, creatinine and various electrolytes, including Na, K, Ca, Mg, Cl and HPO4, were recorded for each patient. Blood pH and the partial pressures of oxygen and carbon dioxide in the blood (PaO2 and PaCO2) were measured using a RapidLab Blood Gas Analyzer (GEM~r~Premiertm 4000 plus). HCMA was evaluated in emergency department, using the following formula: ((pH x HCO3^-^) / Cl-), where pH is the arterial pH, HCO3^-^ is the arterial bicarbonate concentration and Cl- is the arterial chloride concentration, as reported by ABG analysis, on admission to the Emergency Department.

**Statistical Analysis**

Data analyses were performed using SPSS, Version 19.0 (IBM Corp, Armonk, NY). Statistical significance was set at p\<0.05 for all procedures. Analyses of ABG were made using a non-parametric U-test by Mann-Whitney for independent sample. Data are presented as percentage and mean ± standard error (SE).

Results:
========

134 patients with the mean age of 76.5 ± 3.1 (68-85) years were enrolled (64 non-AKI and 70 AKI; 64% female). Baseline characteristics of studied patients are reported in [table 1](#T1){ref-type="table"}. Two groups were similar regarding mean age (p = 0.251), sex (p = 0.091), APACHII score (p = 0.215), Charlson Comorbidity Index (p= 0.187), and body mass index (p = 0.129). [Table 2](#T2){ref-type="table"} summarizes the ABG, electrolyte findings of studied patients. The mean HCMA level was 1.98 ± 0.09 in the non-AKI group and 1.56 ± 0.07 in the AKI group (p=0.039). [Figure 1](#F1){ref-type="fig"} shows the correlation of HCMA and e-GFR levels in AKI patients. There was a positive correlation between HCMA and e-GFR levels in AKI group (r: 0.467, p=0.0092).

Discussion:
===========

In this paper we reported the differences of HCMA levels in non-AKI and AKI patients in the emergency department. In AKI patients a significant association between ABG derived hyperchloremic metabolic acidosis state and e-GFR was found.

###### 

Baseline characteristics of studied patients

  **Variables**                              **non-AKI (n=64)**   **AKI (n=70)**   **P value**
  ------------------------------------------ -------------------- ---------------- -------------
  **Sex**                                                                          
  Male                                       22 (34.3)            26 (37.1)        0.091
  Female                                     42 (65.7)            44 (62.9)        
  **Age (years)**                                                                  
  Mean± SE                                   75±4                 77±3             0.251
  **APACHE II score**                                                              
  Mean± SE                                   22±3                 24±4             0.215
  **Charlson Comorbidity Index**                                                   
  Mean± SE                                   4.0 ±1.8             4.0 ±1.3         0.187
  **BMI (Kg/m** ^2^ **)**                                                          
  Mean± SE                                   21.2 ± 6.0           22.3 ± 5.0       0.129
  **Serum Creatinine (mg/dl)**                                                     
  Mean± SE                                   0.79 ± 0.02          2.06 ± 0.01      0.0091
  **e-GFR** **(ml/min/1.73 m** **2** **)**                                         
  Mean± SE                                   91.3 ± 0.45          33.4 ± 0.25      0.0087
  **Comorbid disease**                                                             
  Diabetes                                   22 (31)              33 (47)          0.041
  Hypertension                               44 (59)              35 (50)          0.101
  Cirrhosis                                  2 (3)                5 (10)           0.037
  COPD                                       6 (10)               8 (11)           0.180
  Heart Failure                              11 (17)              15 (21)          0.140

Data are presented as mean ± standard error (SE) or number (%). APACHE: Acute Physiology and Chronic Health Evaluation; BMI: Body Mass Index; COPD: Chronic Obstructive Pulmonary Disease.

###### 

Laboratory findings of studied patients

  **Variables**                       **non-AKI (n=64)**   **AKI (n=70)**        **P value**
  ----------------------------------- -------------------- --------------------- -------------
  **Arterial blood gas parameters**                                              
  pH                                  7.44 (7.43-7.46)     7.35 (7.35-7.41)      0.131
  pCO2                                43 (41-44)           45 (42-44)            0.110
  pO2                                 65 (61-70)           60 (62-71)            0.197
  HCO3-                               25.4 (24.5-26.3)     22.5 (21.3-23.7)      0.021
  **Serum electrolyte**                                                          
  Na+                                 136 (135-139)        137 (135-140)         0.199
  K+                                  4.5 (4.1-5.1)        5.0 (4.5-5.3)         0.213
  Cl-                                 95.3 (90.6-102.1)    106.4 (104.2-108.8)   0.046
  **(pH x HCO3** ^-^ **) / Cl** ^-^                                              
  HCMA                                1.98 (1.73-2.08)     1.56 (1.48-1.65)      0.039

Data are presented with 95% confidence interval. HCMA: hyperchloremic metabolic acidosis level.
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AKI is associated with higher mortality in emergency patients ([@B9], [@B10]). It has been reported that hyperchloremic acidosis due to the intraoperative chloride load also has an important role in deterioration of renal function ([@B11]). Thus, early identification of AKI patients is crucial for their prompt management. Acute kidney injury can lead to hyperchloremic metabolic acidosis especially when the glomerular filtration rate is between 30 to 59 mL/min (stage III) (12, 13). HCMA has been reported in AKI patients ([@B4]). In fact, to maintain normal pH, the kidneys have to perform two physiological functions. The first is to reabsorb all the filtered HCO3^-^. The second is to excrete the daily H+ load ([@B14]). In particular, during the early phases of AKI, progressive hyperammonemia results in hyperchloremic metabolic acidosis because of impairment in renal ammonia excretion ([@B15]). In the course of AKI there are no classic physical signs and symptoms in the early stage to alert the clinician of ongoing injury. Identifying individuals with suspicion for developing AKI in the ED is of increasing interest. In fact, the present data suggest that the ABG derived formula, for evaluation of HCMA state, may have a potential to be used as a screening test, for early diagnosis of AKI in emergency patients. These data are crucial, because actually the diagnosis of AKI is usually based on changes in serum creatinine. In this regard, serum creatinine is a less rapid indicator of acute renal dysfunction and it may lead to a delay in the diagnosis of AKI. On this note, we found a linear positive correlation between the levels of HCMA, as evaluated by the ABG derived formula, and the impairment of renal function (e-GFR). This is the first study that shows such an association in AKI patients in ED. If confirmed and validated in a future study, the use of ABG derived formula for HCMA may represent a useful tool for early detection of AKI in the emergency department. It seems that HCMA level may be a useful tool for the early detection of AKI within the first few hours of admission.

**Limitations**

Limitations of the present study are mainly represented by the retrospective study design. In this regard, a future large prospective study may be needed to confirm the present findings.

Conclusion:
===========

This is the first report that shows an association between HCMA level and AKI in emergency department patients. If confirmed and validated in a future study, the use of ABG derived formula for HCMA may represent a useful tool for early detection of AKI patients in emergency department.
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